Work

Dinaciclib, a CDK Inhibitor, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.479.479

Authors: David Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby, Robert shmookler Reis

Institutions: University of Arkansas for Medical Sciences, John L. McClellan Memorial Veterans Hospital

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979457340

FWCI: 0.322

Cites:

Cited by: 2

Related to: 10